| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
16,031 |
11,126 |
$901K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
13,916 |
9,724 |
$78K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,154 |
6,852 |
$6K |
| 99001 |
|
6,099 |
4,110 |
$203.85 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
503 |
450 |
$41.78 |
| 81321 |
|
146 |
97 |
$2.46 |
| 81250 |
|
94 |
62 |
$0.00 |
| 81351 |
|
113 |
81 |
$0.00 |
| 81345 |
|
66 |
48 |
$0.00 |
| 81209 |
|
143 |
95 |
$0.00 |
| 81223 |
|
142 |
96 |
$0.00 |
| 81279 |
|
112 |
80 |
$0.00 |
| 81320 |
|
67 |
49 |
$0.00 |
| 81242 |
|
94 |
61 |
$0.00 |
| 81338 |
|
65 |
48 |
$0.00 |
| 81307 |
|
144 |
96 |
$0.00 |
| 81470 |
|
97 |
74 |
$0.00 |
| 81233 |
|
112 |
80 |
$0.00 |
| 81241 |
|
95 |
62 |
$0.00 |
| 81275 |
|
124 |
84 |
$0.00 |
| 81305 |
|
94 |
62 |
$0.00 |
| 81249 |
|
143 |
95 |
$0.00 |
| 81218 |
|
143 |
96 |
$0.00 |
| 81238 |
|
75 |
50 |
$0.00 |
| 81334 |
|
91 |
61 |
$0.00 |